Asthenia

"Asthenia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Clinical sign or symptom manifested as debility, or lack or loss of strength and energy.

Descriptor ID	D001247
MeSH Number(s)	C23.888.089
Concept/Terms	Asthenia Asthenia

Below are MeSH descriptors whose meaning is more general than "Asthenia".

Diseases [C]
Pathological Conditions, Signs and Symptoms [C23]
Signs and Symptoms [C23.888]
Asthenia [C23.888.089]

Below are MeSH descriptors whose meaning is more specific than "Asthenia".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Asthenia" by people in this website by year, and whether "Asthenia" was a major or minor topic of these publications.

Bar chart showing 15 publications over 14 distinct years, with a maximum of 2 publications in 1998

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	1	0	1
1995	1	0	1
1996	1	0	1
1998	1	1	2
2000	1	0	1
2001	1	0	1
2003	0	1	1
2006	0	1	1
2008	0	1	1
2009	0	1	1
2010	0	1	1
2011	1	0	1
2014	0	1	1
2017	0	1	1

Below are the most recent publications written about "Asthenia" by people in Profiles.

Lortholary O, Chandesris MO, Bulai Livideanu C, Paul C, Guillet G, Jassem E, Niedoszytko M, Barete S, Verstovsek S, Grattan C, Damaj G, Canioni D, Fraitag S, Lhermitte L, Georgin Lavialle S, Frenzel L, Afrin LB, Hanssens K, Agopian J, Gaillard R, Kinet JP, Auclair C, Mansfield C, Moussy A, Dubreuil P, Hermine O. Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study. Lancet. 2017 02 11; 389(10069):612-620.

View in: PubMed
Marin D. Patient with chronic myeloid leukemia in complete cytogenetic response: what does it mean, and what does one do next? J Clin Oncol. 2014 Feb 10; 32(5):379-84.

View in: PubMed
Guo Y, Shin KY, Hainley S, Bruera E, Palmer JL. Inpatient rehabilitation improved functional status in asthenic patients with solid and hematologic malignancies. Am J Phys Med Rehabil. 2011 Apr; 90(4):265-71.

View in: PubMed
Whittaker SJ, Demierre MF, Kim EJ, Rook AH, Lerner A, Duvic M, Scarisbrick J, Reddy S, Robak T, Becker JC, Samtsov A, McCulloch W, Kim YH. Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma. J Clin Oncol. 2010 Oct 10; 28(29):4485-91.

View in: PubMed
Baker J, Ajani J, Scotté F, Winther D, Martin M, Aapro MS, von Minckwitz G. Docetaxel-related side effects and their management. Eur J Oncol Nurs. 2009 Feb; 13(1):49-59.

View in: PubMed
Baker J, Ajani J, Scotté F, Winther D, Martin M, Aapro MS, von Minckwitz G. Docetaxel-related side effects and their management. Eur J Oncol Nurs. 2008 Jul; 12(3):253-68.

View in: PubMed
Hong DS, Abbruzzese JL, Bogaard K, Lassere Y, Fukushima M, Mita A, Kuwata K, Hoff PM. Phase I study to determine the safety and pharmacokinetics of oral administration of TAS-102 in patients with solid tumors. Cancer. 2006 Sep 15; 107(6):1383-90.

View in: PubMed
Bruera E, Sweeney C. General keynote: patient support. Gynecol Oncol. 2003 Jan; 88(1 Pt 2):S124-8; discussion S134-5.

View in: PubMed
Bruera E, Beattie-Palmer LN. Pharmacologic management of nonpain symptoms in surgical patients. Surg Oncol Clin N Am. 2001 Jan; 10(1):89-107.

View in: PubMed
Bruera E, Sweeney C. Cachexia and asthenia in cancer patients. Lancet Oncol. 2000 Nov; 1:138-47.

View in: PubMed

People

Explore

Similar Concepts

Top Journals